Moreover, we noticed that the co‐silencing of endoglin (in stromal cells treated with siSynt) reduces the level of EEF1A2 in AML, markedly in U937 and OCI‐AML3, but not significantly in HL60 cells (Fig EV2D). Here, EEF1A2 is linked to acute myeloid leukemia.